Evaluation of Dupilumab in Children With Uncontrolled Asthma (Liberty Asthma Voyage)

Condition:   Asthma
Interventions:   Drug: dupilumab SAR231893 (REGN668);   Drug: Placebo;   Drug: Asthma Reliever Therapies;   Drug: Asthma Controller Therapies (Incl. prednisone/prednisolone)
Sponsors:   Sanofi;   Regeneron Pharmaceuticals
Not yet recruiting – verified October 2016

View full post on ClinicalTrials.gov: asthma | Studies received in the last 14 days

Leave a Reply

Your email address will not be published. Required fields are marked *